[Factors, mediating the immunomodulating effect of met-enkephalin: effect of mitogen dose, stage of cellular activation, and time of opioid introduction].
Dubinin
K V
KV
Zakharova
L A
LA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002455:Cell Division / Q000187:drug effects*; D003208:Concanavalin A / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004744:Enkephalin, Methionine / Q000494:pharmacology*; D005260:Female; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D018847:Opioid Peptides / Q000008:administration & dosage / Q000494:pharmacology*
D000276:Adjuvants, Immunologic; D018847:Opioid Peptides; D003208:Concanavalin A; D004744:Enkephalin, Methionine